See more : Ares Commercial Real Estate Corporation (ACRE) Income Statement Analysis – Financial Results
Complete financial analysis of Many Bright Ideas Technologies Inc. (MBGNF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Many Bright Ideas Technologies Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Elanders AB (publ) (ELAN-B.ST) Income Statement Analysis – Financial Results
- Alliance Recovery Corporation (ARVY) Income Statement Analysis – Financial Results
- Capital Finance Holdings Limited (8239.HK) Income Statement Analysis – Financial Results
- Superior Gold Inc. (SGI.V) Income Statement Analysis – Financial Results
- Kimberly Parry Organics Inc. (KPOC) Income Statement Analysis – Financial Results
Many Bright Ideas Technologies Inc. (MBGNF)
About Many Bright Ideas Technologies Inc.
Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company was formerly known as Med BioGene Inc. and changed its name to Many Bright Ideas Technologies Inc. in June 2022. Many Bright Ideas Technologies Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 58.11K | 63.06K | 59.96K | 54.54K | 63.48K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 58.11K | 63.06K | 59.96K | 54.54K | 63.48K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 58.11K | 63.06K | 59.96K | 54.54K | 63.48K |
| Cost & Expenses | 58.11K | 63.06K | 59.96K | 54.54K | 63.48K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 45.98K | 49.58K | 59.96K | 54.54K | 63.48K |
| EBITDA | -12.13K | -13.48K | 0.00 | 0.00 | -1.48K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -58.11K | -63.06K | -59.96K | -54.54K | -63.48K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -58.11K | -63.06K | -59.96K | -54.54K | -63.48K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 1.07K | -63.06K | -59.96K | -54.54K | 0.00 |
| Net Income | -58.11K | -63.06K | -59.96K | -54.54K | -63.48K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Weighted Avg Shares Out | 17.26M | 17.26M | 15.22M | 13.26M | 11.25M |
| Weighted Avg Shares Out (Dil) | 17.26M | 17.26M | 15.22M | 13.26M | 11.25M |
Source: https://incomestatements.info
Category: Stock Reports